These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33615747)

  • 21. Outcome of ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registry.
    Lang H; de Santibanes E; Clavien PA
    HPB (Oxford); 2017 May; 19(5):379-380. PubMed ID: 28262523
    [No Abstract]   [Full Text] [Related]  

  • 22. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
    Welzel TM; Graubard BI; El-Serag HB; Shaib YH; Hsing AW; Davila JA; McGlynn KA
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1221-8. PubMed ID: 17689296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Descriptive epidemiology of bile duct carcinoma in Osaka.
    Ikeda A; Miyashiro I; Nakayama T; Ioka A; Tabuchi T; Ito Y; Tsukuma H
    Jpn J Clin Oncol; 2013 Nov; 43(11):1150-5. PubMed ID: 24014885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry.
    Satake T; Morizane C; Rikitake R; Higashi T; Okusaka T; Kawai A
    J Gastroenterol; 2022 Nov; 57(11):890-901. PubMed ID: 36161533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ASO Author Reflections: Re-resection of Positive Bile Duct Margin for Hilar Cholangiocarcinoma.
    Bagante F; Pawlik TM
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):784-785. PubMed ID: 30288652
    [No Abstract]   [Full Text] [Related]  

  • 26. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
    Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
    J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholangiocarcinoma in Germany: Epidemiologic trends and impact of misclassification.
    Walter D; Ferstl P; Waidmann O; Trojan J; Hartmann S; Schnitzbauer AA; Zeuzem S; Kraywinkel K
    Liver Int; 2019 Feb; 39(2):316-323. PubMed ID: 30176117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulators of apoptosis in cholangiocarcinoma.
    Jhala NC; Vickers SM; Argani P; McDonald JM
    Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise.
    Saha SK; Zhu AX; Fuchs CS; Brooks GA
    Oncologist; 2016 May; 21(5):594-9. PubMed ID: 27000463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholangiocarcinoma at the hepatic hilus: sonographic findings.
    Hann LE; Greatrex KV; Bach AM; Fong Y; Blumgart LH
    AJR Am J Roentgenol; 1997 Apr; 168(4):985-9. PubMed ID: 9124155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
    Yan Y; Lu N; Tian W; Liu T
    Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis.
    Kim JK; Hwang HK; Park JS; Cho SI; Yoon DS; Chi HS
    J Surg Oncol; 2008 Aug; 98(2):139-42. PubMed ID: 18521837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence, Mortality, and Survival Trends in Cancer of the Gallbladder and Extrahepatic Bile Ducts in Lithuania.
    Dulskas A; Cerkauskaite D; Patasius A; Smailyte G
    Medicina (Kaunas); 2023 Mar; 59(4):. PubMed ID: 37109618
    [No Abstract]   [Full Text] [Related]  

  • 34. Liver transplantation for intra- and extrahepatic cholangiocarcinoma.
    Schmeding M; Neumann UP
    Ann Transplant; 2013 Jan; 18():1-8. PubMed ID: 23792495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current epidemiology of cholangiocarcinoma in Western countries.
    Vithayathil M; Khan SA
    J Hepatol; 2022 Dec; 77(6):1690-1698. PubMed ID: 35977611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precision Hilar Cholangiocarcinoma Surgery.
    Aloia TA
    Ann Surg Oncol; 2018 May; 25(5):1103-1104. PubMed ID: 29520653
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical presentation, diagnosis, and survival in cholangiocarcinoma: A prospective study.
    Vasilieva L; Papadhimitriou SI; Alexopoulou A; Kostopoulos I; Papiris K; Pavlidis D; Xinopoulos D; Romanos A; Dourakis SP
    Arab J Gastroenterol; 2016 Dec; 17(4):181-184. PubMed ID: 27914884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study.
    Nanashima A; Yamaguchi H; Shibasaki S; Ide N; Sawai T; Tsuji T; Hidaka S; Sumida Y; Nakagoe T; Nagayasu T
    J Gastroenterol; 2004 Nov; 39(11):1095-101. PubMed ID: 15580404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing incidence of cholangiocarcinoma in Crete 1992-2000.
    Mouzas IA; Dimoulios P; Vlachonikolis IG; Skordilis P; Zoras O; Kouroumalis E
    Anticancer Res; 2002; 22(6B):3637-41. PubMed ID: 12552969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative drainage for perihilar cholangiocarcinoma.
    Singh A; Rathi S; Kalra N; Gorsi U; Singh V
    Lancet Gastroenterol Hepatol; 2019 Jan; 4(1):10. PubMed ID: 30527575
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.